SUPHA PHARMACHEM LIMITED Share Price

₹ 0.27

+0.00 (0.00%)
1D
Last updated 06 Nov, 2026, 15:29 IST
BSE: 539561
|
Trading

SUPHA PHARMACHEM LIMITED Share Price Today

As of 8 Nov 2026, SUPHA PHARMACHEM LIMITED share price is ₹0.27. The stock opened at ₹0.26, compared to its previous close of ₹0.27. During today's trading session, SUPHA PHARMACHEM LIMITED share price moved in the range of ₹0.26 to ₹0.27, with an average price of ₹0.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹0.23 and a high of ₹1.60.

Share price over the last 1 day rose from 0.26 to 0.27, ranging between 0.26 and 0.27.
₹0.26
0.00% up today
₹0.27
1D LOW
1D HIGH

SUPHA PHARMACHEM LIMITED Stock Insights

Latest Earning
Op Profit TrendUp by 82.84% QoQ
Latest Earning
Net Profit TrendUp by 85.38% QoQ
Latest Earning
Revenue TrendDown by 2.17% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 79.38 % in last 1 yr
SUPHA PHARMACHEM LIMITED stock performance
Open₹0.26
High₹0.27
Low₹0.26
Prev. close₹0.27
SUPHA PHARMACHEM LIMITED trading activity
Volume6,93,856
Average traded price₹0.26
Last traded time03:29:50 06 Nov
Last traded quantity100
Circuit
L
H
₹0.26
₹0.28
52-week
L
H
₹0.23
₹1.60
Mkt Cap Cr
23.81
P/E
36.4
P/B
1.67
ROA
0.18%
ROE
4.85%
ROCE
1.01%
Quick Ratio
0.87
EV/EBITDA
100.58

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Remedium Life outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Remedium Life appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Remedium Life earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,46,276.3040.625.09.61%13.79%18.65%2.3122.94
Divis Laboratories2,73,565.3793.5316.3214.6%15.32%19.56%3.561.17
Torrent Pharmaceuticals1,80,332.4085.929.814.7%11.42%11.37%0.7534.53
Laurus Labs1,26,703.2294.6920.8211.58%22.11%20.91%0.6853.3
Zydus Lifesciences1,19,201.7127.714.297.63%15.1%14.86%0.9115.94
Dr. Reddy's Laboratories1,14,532.4441.52.954.79%7.21%8.58%1.3519.25
Cipla1,13,828.9739.883.226.6%8.18%10.8%2.521.42
Mankind Pharma1,04,913.4546.355.977.82%12.76%14.68%0.7425.26
Aurobindo Pharma1,03,395.4125.932.626.46%10.13%12.76%1.1512.38
Lupin91,001.3117.433.7813.08%21.65%24.54%1.4210.19

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SUPHA PHARMACHEM LIMITED Company Background

ISIN
INE549S01036
Sector Market Cap
₹ 23.81 Cr

Supha Pharmachem Limited, formerly Remedium Lifecare Limited, is an India-based pharmaceutical and specialty chemicals company engaged in trading and distribution of raw materials for the pharmaceutical industry. The Company is engaged in the business of trading in advanced pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and other pharma products used viz. Isopropyl Alcohol (IPA) ,Cyclohexane, Diisopropyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Methylene Dichloride, Potassium Carbonate Powder, Sodium Bicarbonate, Potassium Hydroxide Flakes, Sodium Chloride (common salt), Sodium Carbonate (soda ash), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, and Trimethyl Sulfoxonium Iodide (TMSI).

SUPHA PHARMACHEM LIMITED Financial Highlights

  • Revenue: SUPHA PHARMACHEM LIMITED reported revenue of ₹233.30 crore in FY25 vs ₹4,062.79 crore in FY24. It showed a decrease of 94.26% on a yearly basis.
  • Operating Profit: SUPHA PHARMACHEM LIMITED reported an operating profit of ₹3.66 crore in FY25 vs ₹50.45 crore in FY24. It showed a decrease of 92.75% on a year-on-year basis.
  • Net Profit: SUPHA PHARMACHEM LIMITED reported a net profit of ₹1.53 crore in FY25 vs ₹32.73 crore in FY24. It showed a decrease of 95.33% on a yearly basis.

SUPHA PHARMACHEM LIMITED Quarterly Result Highlights

  • SUPHA PHARMACHEM LIMITED reported revenue of ₹114.31 crore in Sep 2025, compared with ₹116.85 crore in Jun 2025, representing a decrease of 2.17% on a quarter-on-quarter (QoQ) basis.
  • SUPHA PHARMACHEM LIMITED reported an operating profit of ₹10.44 crore in Sep 2025, compared with ₹5.71 crore in Jun 2025, representing an increase of 82.84% on a quarter-on-quarter (QoQ) basis.
  • SUPHA PHARMACHEM LIMITED reported a profit of ₹8.62 crore in Sep 2025, compared with ₹4.65 crore in Jun 2025, reflecting an increase of 85.38% on a QoQ basis.
  • The earnings per share (EPS) of SUPHA PHARMACHEM LIMITED stood at ₹0.05 during Sep 2025.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
1.13%
FII
1.70%
Other DII
0.00%
Retail and other
97.17%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20250.00%
Jun 20250.00%
Sep 20250.00%
Dec 20251.70%

SUPHA PHARMACHEM LIMITED Investment Returns

1 day
--
1 week
+17.39%
1 month
+3.85%
1 year
-82.69%
3 years
-95.18%
5 years
+12.50%

SUPHA PHARMACHEM LIMITED Share Price History

SUPHA PHARMACHEM LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
06 Nov 26
₹0.26 / ₹0.27
0.00%
05 Nov 26
₹0.26 / ₹0.27
+3.85%
04 Nov 26
₹0.25 / ₹0.26
+4.00%
03 Nov 26
₹0.24 / ₹0.25
+4.17%
Show more

SUPHA PHARMACHEM LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025
Revenue₹405.25
Other Income₹10.80
Total Revenue₹416.05
Total Expenses₹411.67
Profit Before Tax₹4.38
Tax₹2.26
Profit After Tax₹2.13
EPS - Basic₹0.05
EPS - Diluted₹0.05

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025
Profit before tax₹4.38
Income before WC changes₹9.58
Change in Assets-₹1,679.45
Change in Liabilities₹535.06
Change in WC-₹1,144.39
Cash flow from Operations-₹1,134.81
Cash flow from Investing₹0.13
Cash flow from Financing₹1,136.10
Total Cash Flow₹1.43
Cash (Start of the year)₹0.00
Cash (End of the year)₹1.43

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025
Non-Current Assets₹0.04
Current Assets₹1,720.30
Total Assets₹1,720.35
Current Liabilities₹1,676.46
Net Current Asset₹43.85
Non-Current Liabilities₹0.00
Equity Capital₹43.89
Total Equity & Liabilities₹1,720.35

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹222.50₹4,041.71₹509.84₹504.79
Other Income₹10.80₹21.08₹0.00₹0.00
Total Revenue₹233.30₹4,062.79₹509.84₹504.79
Total Expenses₹229.64₹4,012.33₹502.44₹503.27
Profit Before Tax₹3.66₹50.45₹7.40₹1.53
Tax₹2.13₹17.72₹1.97₹0.45
Profit After Tax₹1.53₹32.73₹5.43₹1.08
EPS - Basic₹0.04₹3.25₹15.07₹2.99
EPS - Diluted₹0.04₹3.25₹15.07₹2.99

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹3.66₹50.45₹7.40₹1.53
Income before WC changes₹8.86₹54.29₹7.58₹1.71
Change in Assets₹405.30-₹813.04-₹910.15-₹184.62
Change in Liabilities-₹1,492.30₹702.40₹925.04₹194.65
Change in WC-₹1,087.00-₹110.64₹14.89₹10.03
Cash flow from Operations-₹1,078.63-₹74.16₹20.50₹11.28
Cash flow from Investing₹0.06₹0.00-₹0.04-₹0.05
Cash flow from Financing₹1,078.40₹53.83-₹0.04-₹10.61
Total Cash Flow-₹0.16-₹20.33₹20.42₹0.62
Cash (Start of the year)₹1.52₹21.86₹1.44₹0.81
Cash (End of the year)₹1.36₹1.52₹21.86₹1.44

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.11₹0.07₹0.09₹0.19
Current Assets₹1,539.54₹1,947.85₹1,154.14₹223.57
Total Assets₹1,539.65₹1,947.92₹1,154.22₹223.76
Current Liabilities₹1,496.35₹1,904.97₹1,143.86₹218.82
Net Current Asset₹43.19₹42.88₹10.28₹4.75
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹43.30₹42.96₹10.36₹4.94
Total Equity & Liabilities₹1,539.65₹1,947.92₹1,154.22₹223.76
* All values are in INR Crore
SUPHA PHARMACHEM LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
000.27514914
0000
0000
0000
0000
Total bid quantity0
Total ask quantity5,14,914
SUPHA PHARMACHEM LIMITED technical summary
Bearish indicators5
Neutral indicators2
Bullish indicators1
OverallStrong Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
58.17
Neutral
ATR (14)
0.02
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
25.9
Bearish
UO(9)
74.14
Bearish
ROC(12)
12.5
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
0.26
0.26
10D
0.25
0.25
20D
0.25
0.25
50D
0.26
0.27
100D
0.29
0.31
Volume trend — traded volume by day
6 Nov6L
5 Nov16L
4 Nov13L
3 Nov12L
2 Nov7L
Average11L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SUPHA PHARMACHEM LIMITED
Trading
Add Stock
Add Another

SUPHA PHARMACHEM LIMITED Returns Calculator

Top Gainers

TTML Share Price
₹39.77
+4.44 (+12.57%)
LINDEINDIA Share Price
₹6859.00
+551 (+8.73%)
APLLTD Share Price
₹965.15
+71.65 (+8.02%)
YESBANK Share Price
₹17.20
+0.96 (+5.91%)
HAVELLS Share Price
₹1128.00
+59.9 (+5.61%)
See more

Top Losers

THERMAX Share Price
₹2746.30
-573.4 (-17.27%)
HAPPYFORGE Share Price
₹1694.50
-188.2 (-10%)
ASTRAL Share Price
₹1253.60
-134.4 (-9.68%)
APARINDS Share Price
₹14106.00
-1507 (-9.65%)
REDINGTON Share Price
₹327.50
-28.9 (-8.11%)
See more

SUPHA PHARMACHEM LIMITED Share Price FAQs

Please be aware that SUPHA PHARMACHEM LIMITED stock prices are subject to continuous fluctuations due to various factors.